Fig. 1
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Flowchart of study population selection including patient recruitment and exclusion criteria.
Fig. 1 | Scientific Reports
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Flowchart of study population selection including patient recruitment and exclusion criteria.
